Pursuant to a recent FDA emergency approval of COVID-19 convalescent plasma treatment with high titers of anti-SARS-CoV-2 antibodies, the CMS has authorized this service for coverage. Effective December 28, 2021, the HCPCS code C9507 must be used to report this treatment in an outpatient setting.
Discover more from Doctor Trusted
Subscribe to get the latest posts sent to your email.
